RMTI: Rockwell Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
Rockwell agrees to buy Vantive's hemodialysis unit for $125M plus up to $45M earnout, funded by seller loans; close mid-2027, $400-450M…
What this filing says
Rockwell Medical agreed to acquire Vantive's in-center hemodialysis business across 35 jurisdictions, including the United States, with the closing expected in mid-2027. The base price is $125 million, financed through two seller-provided term loans and a convertible note issued to Vantive, plus up to $45 million of contingent payments tied to revenue and EBITDA milestones. For shareholders, the deal would add debt and potential dilution from the convertible note, and the company expects the combined business to generate $400 million to $450 million in annual revenue.
Key figures
- Base purchase price
- $125 million
- Each seller term loan
- $50 million
- Convertible note
- $25 million
- Maximum contingent consideration
- $45 million
- Projected combined annual revenue
- $400 million to $450 million
- Expected closing
- mid-2027
Positive for shareholders
- The acquisition would broaden product lines, customer reach and recurring revenue streams.
- Management expects the combined business to reach $400 million to $450 million in annual revenue.
Negative for shareholders
- The purchase is financed largely with seller debt and a convertible note, adding leverage and possible dilution.
- Up to $45 million of additional payments depend on future milestones.
- The deal is subject to closing conditions and is not expected to close until mid-2027.
- Management flagged risks including integration, product quality, recalls and product liability.
Written by Quantisnow AI from this filing. Not financial advice.
Form 8-K cover page
Key terms
- Convertible note:
- A loan that can be exchanged for company shares at a set price, which can dilute existing shareholders if converted.
- SOFR:
- The Secured Overnight Financing Rate, a benchmark interest rate that loan rates are often priced from.
- VWAP:
- Volume-Weighted Average Price, the average trading price of a stock weighted by how many shares traded at each price.
- Contingent consideration:
- Payments that are made only if the acquired business hits specified future targets.
FAQ
How much will Rockwell Medical pay for Vantive's hemodialysis business?
The base purchase price is $125 million, subject to customary adjustments, plus up to $45 million of contingent consideration based on revenue and EBITDA milestones.
When is the Rockwell Medical acquisition of Vantive expected to close?
The company expects the acquisition to close in mid-2027, subject to the terms and conditions of the agreement.
Historical context for RMTI
Across the 24 sessions after earlier RMTI headlines, the stock closed higher 14 times and lower 10 times, with a median move of 3.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | RMTI | SPY |
|---|---|---|---|
| Nov 3, 2026 | Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medicaland 1 other headline that session | +17.1% | +0.3% |
| Oct 15, 2026 | Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026 | +4.2% | +0.3% |
| Oct 14, 2026 | Rockwell Medical to Exhibit at ASN Kidney Week 2026 | -2.4% | -1.1% |
| Oct 7, 2026 | Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production’ List | +7.5% | -0.2% |
| Aug 13, 2026 | Rockwell Medical Announces Second Quarter 2026 Results | +4.2% | +0.7% |
| Jul 22, 2026 | Rockwell Medical Advances Quality and Regulatory Leadership | +2.3% | -0.1% |
Keep researching RMTI
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- RMTI insider tradesEvery buy and sale reported by Rockwell Medical Inc. officers, directors and large holders.
- RMTI earnings historyPast Rockwell Medical Inc. earnings releases, newest first.
- RMTI financial statementsRevenue, profit, cash flow and balance sheet from Rockwell Medical Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 1998
Follow RMTI and get a push notification the moment its next story breaks.